In a recent Select Science Editorial Article, Dr. Harald Messer, Gene Therapies Senior Scientist at Novartis, talks about the key considerations and challenges associated with developing biologically relevant cell-based assays that reflect mechanisms of action (MoA) and drug potency that represent ... Read more
In a recent interview by Select Science, Heather Watson, Senior Manager in the Immunochemistry Department at Labcorp highlights how the industry is improving patient care by delivering innovative solutions that support faster and more cost-effective treatment. Read more
In a recent Select Science Editorial Article, Dr. Erik Tillman, Principal Scientist at Akero Therapeutics, describes his company’s quest to find an effective treatment for non-alcoholic steatohepatitis and how the functional iLite assay-ready cells they use deliver robust, reproducible, and ... Read more
